Skip to Main Content

Paper Details

Combined Effect of a Polygenic Risk Score and Rare Genetic Variants on Prostate Cancer Risk.
Eur Urol
36
2021
ATM, BRCA2, CHEK2, CHEK2 P, G84E, HOXB13, HOXB13 G84E, PATIENT, Polygenic, Prostate Cancer, Rare Genetic Variants, germline variants, man, men, prostate cancer, rare variants
Author NameAffiliation
Burcu F DarstCenter for Genetic Epidemiology, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center
Burcu F DarstCenter for Genetic Epidemiology, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center
Rosalind A EelesThe Institute of Cancer Research, UK The Royal Marsden NHS Foundation Trust
Zsofia Kote-JaraiThe Institute of Cancer Research
David V ContiCenter for Genetic Epidemiology, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center
Christopher A HaimanCenter for Genetic Epidemiology, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center
Christopher A HaimanCenter for Genetic Epidemiology, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center
  • 1 - 7

Datasets

Release 1.2